시장보고서

상품코드

1671179

세계의 노인용 의약품 시장, 규모, 점유율, 동향, 산업 분석 보고서 : 치료제별, 상태별, 유통 채널별, 지역별 - 예측(2025-2034년)

Global Geriatric Medicines Market Size, Share, Trends, Industry Analysis Report: By Therapeutics, Condition, Distribution Channel, and Region - Market Forecast, 2025-2034

발행일: 2025년 02월 | 리서치사:

Polaris Market Research | 페이지 정보: 영문 117 Pages | 배송안내 : 1-2일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

Polaris Market Research의 최신 조사에 따르면 세계 노인용 의약품 시장 규모는 2034년까지 3,405억 달러에 이를 것으로 예상됩니다. 이 설문조사 보고서는 현재 시장 역학을 자세히 파악하고 향후 시장 성장에 대한 분석을 제공합니다.

노인용 의약품은 노인 약물 치료로도 알려져 있으며 노인을 위해 특별히 고안된 의약품 치료의 개발, 사용 및 관리에 중점을 둔 의학 전문 분야를 말합니다. 이 분야는 심혈관 질환, 당뇨병, 관절염, 신경 질환, 호흡기 질환 등의 만성 질환을 포함한 노화와 관련된 독특한 생리적 변화와 건강 문제를 해결합니다.

노인용 의약품 시장은 세계 고령화 인구 증가와 심혈관 질환, 당뇨병, 관절염, 신경 퇴행성 질환과 같은 만성 질환 및 노화 관련 질병의 유병률의 상승에 의해 견인되고 있습니다. 이 시장의 주요 비즈니스 기회로는 맞춤형 의료의 발전, 나이에 특화된 약물 제제 개발, 신흥국 시장의 건강 관리 인프라 확대 등이 있습니다.

원격 의료 및 웨어러블 단말기와 같은 디지털 건강 기술의 통합과 같은 동향은 노인 치료에 대한 액세스를 향상시키고 치료의 어드레싱을 개선합니다. 또한 예방 의료 및 바이오시밀러에 대한 투자도 증가하고 있으며 비용 효율적인 솔루션을 제공합니다. 전반적으로 노인 의약품 시장은 혁신적이고 사용하기 쉬운 치료에 대한 수요가 세계적으로 증가하고 있기 때문에 안정적인 성장이 예상됩니다.

노인용 의약품 시장 보고서 하이라이트

고령자의 당뇨병 유병률이 높아짐에 따라 항당뇨병약 분야가 시장을 독점하고 있으며 GLP-1 수용체 작용제 등 혁신적 치료제에 대한 수요 증가가 성장을 이끌고 있습니다.

고령자의 심장 관련 질환의 부담이 크므로, 순환기계 질환이 최대 시장 점유율을 차지하는 한편, 알츠하이머병이나 파킨슨병의 유병률 증가에 의해 신경계 질환이 가장 급성장하고 있습니다.

한편, 온라인 약국은 재택 배송의 편의성과 디지털 헬스 플랫폼의 채용 증가에 따라 급성장을 기록하고 있습니다.

북미는 진보된 건강 관리 인프라와 노인 인구 증가에 의해 지원되고 시장을 독점합니다. 반면 아시아태평양은 노인 인구 확대와 의료 접근 개선에 힘입어 가장 급성장하는 지역입니다.

시장 현황
노인용 의약품 시장 역학
- 성장 촉진요인과 기회
  - 연령에 따른 의약품 수요 증가
  - 고령 환자용 맞춤형 의료의 진보
- 억제요인과 과제
  - 고령자 헬스케어의 고액의 비용
PESTEL 분석
노인용 의약품 시장의 응용 동향
밸류체인 분석
COVID-19의 영향 분석

제5장 세계의 노인용 의약품 시장 : 치료제별

주요 조사 결과
소개
진통제
스타틴
항당뇨병약
양성자 펌프 억제제(PPI)
항응고제
항정신병약
기타

제6장 세계 노인용 의약품 시장 : 상태별

주요 조사 결과
소개
심혈관 질환
신경질환
암
당뇨병과 대사 장애
호흡기 질환
기타

제7장 세계의 노인용 의약품 시장 : 유통 채널별

주요 조사 결과
소개
병원 약국
소매 약국
온라인 약국

제8장 세계의 노인용 의약품 시장 : 지역별

주요 조사 결과
소개
- 노년용 의약품 시장의 평가, 지역, 2020년-2034년
북미
- 북미 : 치료제별, 2020년-2034년
- 북미 : 상태별, 2020년-2034년
- 북미 : 유통 채널별, 2020년-2034년
- 미국
- 캐나다
유럽
- 유럽 : 치료제별, 2020년-2034년
- 유럽 : 상태별, 2020년-2034년
- 유럽 : 유통 채널별, 2020년-2034년
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
아시아태평양
- 아시아태평양: 치료제별, 2020년-2034년
- 아시아태평양: 상태별, 2020년-2034년
- 아시아태평양: 유통 채널별, 2020년-2034년
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
중동 및 아프리카
- 중동 및 아프리카: 치료제별, 2020년-2034년
- 중동 및 아프리카 : 상태별, 2020년-2034년
- 중동 및 아프리카 : 유통 채널별, 2020년-2034년
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 남아프리카
- 기타 중동 및 아프리카
라틴아메리카
- 라틴아메리카 : 치료제별, 2020년-2034년
- 라틴아메리카 : 상태별, 2020년-2034년
- 라틴아메리카 : 유통 채널별, 2020년-2034년
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카

제9장 경쟁 구도

확대 및 인수 분석
- 확대
- 인수
제휴, 협업, 합의, 공개

제10장 기업 프로파일

Pfizer Inc.
Novartis International AG
Sanofi
GlaxoSmithKline
Merck & Co.
AbbVie
AstraZeneca
Johnson & Johnson
Eli Lilly and Company
Roche

SHW 25.03.18

The global geriatric medicines market size is expected to reach USD 340.50 billion by 2034, according to a new study by Polaris Market Research. The report "Geriatric Medicines Market Size, Share, Trends, Industry Analysis Report: By Therapeutics (Analgesics, Statins, Antidiabetic, Proton Pump Inhibitors (PPIs), Anticoagulant, Antipsychotic, and Others), Condition, Distribution Channel, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Geriatric medicines, also known as geriatric pharmacotherapy, refer to a specialized branch of medicine focused on the development, use, and management of pharmaceutical treatments designed specifically for elderly individuals. This area addresses the unique physiological changes and health challenges associated with aging, including chronic conditions such as cardiovascular diseases, diabetes, arthritis, neurological disorders, and respiratory diseases.

The geriatric medicines market is driven by the growing global aging population and the rising prevalence of chronic and age-related diseases such as cardiovascular conditions, diabetes, arthritis, and neurodegenerative disorders. Key opportunities in the market include advancements in personalized medicine, the development of age-specific drug formulations, and the expansion of healthcare infrastructure in emerging markets.

Trends such as the integration of digital health technologies, including telemedicine and wearable devices, are enhancing access to care and improving treatment adherence among older adults. The market is also seeing increasing investments in preventive healthcare and biosimilars to provide cost-effective solutions. Overall, the geriatric medicines market is poised for steady growth as demand for innovative and accessible treatments continues to rise globally.

Geriatric Medicines Market Report Highlights

The antidiabetic segment dominates the market due to the high prevalence of diabetes among the elderly, with rising demand for innovative treatments such as GLP-1 receptor agonists driving growth.

Cardiovascular diseases account for the largest geriatric medicines market share, driven by the significant burden of heart-related conditions in older adults, while neurological disorders are the fastest-growing segment due to the increasing prevalence of Alzheimer's and Parkinson's diseases.

Hospital pharmacies lead the market as they are primary points of care for elderly patients with chronic diseases, whereas online pharmacies are registering the fastest growth due to the convenience of home delivery and the rising adoption of digital health platforms.

North America dominates the market, supported by advanced healthcare infrastructure and a growing elderly population, while Asia Pacific is the fastest-growing region, fueled by its expanding geriatric demographic and improving healthcare access.

Polaris Market Research has segmented the geriatric medicines market report based on therapeutics, condition, distribution channel, and region:

By Therapeutics Outlook (Revenue-USD Billion, 2020 - 2034)

Analgesics
Statins
Antidiabetic
Proton Pump Inhibitors (PPIs)
Anticoagulant
Antipsychotic
Others

By Condition Outlook (Revenue-USD Billion, 2020 - 2034)

Cardiovascular Diseases
Neurological Disorders
Cancer
Diabetes & Metabolic Disorders
Respiratory Diseases
Others

By Distribution Channel Outlook (Revenue-USD Billion, 2020 - 2034)

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

By Regional Outlook (Revenue-USD Billion, 2020 - 2034)

North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Source
- 3.2.1. Primary Source
- 3.2.2. Secondary Source

4. Global Geriatric Medicines Market Insights

4.1. Geriatric Medicines Market - Market Snapshot
4.2. Geriatric Medicines Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Growing Demand for Age-Specific Medications
  - 4.2.1.2. Advancements in Personalized Medicine for Elderly Patients
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High Cost of Geriatric Healthcare
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Geriatric Medicines Market Application Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Geriatric Medicines Market, by Therapeutics

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
5.3. Analgesics
- 5.3.1. Global Geriatric Medicines Market, by Analgesics, by Region, 2020-2034 (USD Billion)
5.4. Statins
- 5.4.1. Global Geriatric Medicines Market, by Statins, by Region, 2020-2034 (USD Billion)
5.5. Antidiabetic
- 5.5.1. Global Geriatric Medicines Market, by Antidiabetic, by Region, 2020-2034 (USD Billion)
5.6. Proton Pump Inhibitors (PPIs)
- 5.6.1. Global Geriatric Medicines Market, by Proton Pump Inhibitors (PPIs), by Region, 2020-2034 (USD Billion)
5.7. Anticoagulant
- 5.7.1. Global Geriatric Medicines Market, by Anticoagulant, by Region, 2020-2034 (USD Billion)
5.8. Antipsychotic
- 5.8.1. Global Geriatric Medicines Market, by Antipsychotic, by Region, 2020-2034 (USD Billion)
5.9. Others
- 5.9.1. Global Geriatric Medicines Market, by Others, by Region, 2020-2034 (USD Billion)

6. Global Geriatric Medicines Market, by Condition

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
6.3. Cardiovascular Diseases
- 6.3.1. Global Geriatric Medicines Market, by Cardiovascular Diseases, by Region, 2020-2034 (USD Billion)
6.4. Neurological Disorders
- 6.4.1. Global Geriatric Medicines Market, by Neurological Disorders, by Region, 2020-2034 (USD Billion)
6.5. Cancer
- 6.5.1. Global Geriatric Medicines Market, by Cancer, by Region, 2020-2034 (USD Billion)
6.6. Diabetes & Metabolic Disorders
- 6.6.1. Global Geriatric Medicines Market, by Diabetes & Metabolic Disorders, by Region, 2020-2034 (USD Billion)
6.7. Respiratory Diseases
- 6.7.1. Global Geriatric Medicines Market, by Respiratory Diseases, by Region, 2020-2034 (USD Billion)
6.8. Others
- 6.8.1. Global Geriatric Medicines Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Geriatric Medicines Market, by Distribution Channel

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
7.3. Hospital Pharmacy
- 7.3.1. Global Geriatric Medicines Market, by Hospital Pharmacy, by Region, 2020-2034 (USD Billion)
7.4. Retail Pharmacy
- 7.4.1. Global Geriatric Medicines Market, by Retail Pharmacy, by Region, 2020-2034 (USD Billion)
7.5. Online Pharmacy
- 7.5.1. Global Geriatric Medicines Market, by Online Pharmacy, by Region, 2020-2034 (USD Billion)

8. Global Geriatric Medicines Market, by Geography

8.1. Key Findings
8.2. Introduction
- 8.2.1. Geriatric Medicines Market Assessment, b y Geography, 2020-2034 (USD Billion)
8.3. Geriatric Medicines Market - North America
- 8.3.1. North America: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
- 8.3.2. North America: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
- 8.3.3. North America: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.3.4. Geriatric Medicines Market - US
  - 8.3.4.1. US : Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  - 8.3.4.2. US : Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  - 8.3.4.3. U S: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.3.5. Geriatric Medicines Market - Canada
  - 8.3.5.1. Canada: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  - 8.3.5.2. Canada: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  - 8.3.5.3. Canada: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
8.4. Geriatric Medicines Market - Europe
- 8.4.1. Europe: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
- 8.4.2. Europe: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
- 8.4.3. Europe: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.4. Geriatric Medicines Market - UK
  - 8.4.4.1. UK: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  - 8.4.4.2. UK: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  - 8.4.4.3. UK: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.5. Geriatric Medicines Market - France
  - 8.4.5.1. France: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  - 8.4.5.2. France: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  - 8.4.5.3. France: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.6. Geriatric Medicines Market - Germany
  - 8.4.6.1. Germany: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  - 8.4.6.2. Germany: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  - 8.4.6.3. Germany: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.7. Geriatric Medicines Market - Italy
  - 8.4.7.1. Italy: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  - 8.4.7.2. Italy: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  - 8.4.7.3. Italy: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.8. Geriatric Medicines Market - Spain
  - 8.4.8.1. Spain: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  - 8.4.8.2. Spain: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  - 8.4.8.3. Spain: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.9. Geriatric Medicines Market - Netherlands
  - 8.4.9.1. Netherlands: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  - 8.4.9.2. Netherlands: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  - 8.4.9.3. Netherlands: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.10. Geriatric Medicines Market - Russia
  - 8.4.10.1. Russia: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  - 8.4.10.2. Russia: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  - 8.4.10.3. Russia: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.4.11. Geriatric Medicines Market - Rest of Europe
  - 8.4.11.1. Rest of Europe: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  - 8.4.11.2. Rest of Europe: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  - 8.4.11.3. Rest of Europe: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
8.5. Geriatric Medicines Market - Asia Pacific
- 8.5.1. Asia Pacific: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
- 8.5.2. Asia Pacific: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
- 8.5.3. Asia Pacific: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.4. Geriatric Medicines Market - China
  - 8.5.4.1. China: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  - 8.5.4.2. China: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  - 8.5.4.3. China: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.5. Geriatric Medicines Market - India
  - 8.5.5.1. India: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  - 8.5.5.2. India: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  - 8.5.5.3. India: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.6. Geriatric Medicines Market - Malaysia
  - 8.5.6.1. Malaysia: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  - 8.5.6.2. Malaysia: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  - 8.5.6.3. Malaysia: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.7. Geriatric Medicines Market - Japan
  - 8.5.7.1. Japan: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  - 8.5.7.2. Japan: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  - 8.5.7.3. Japan: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.8. Geriatric Medicines Market - Indonesia
  - 8.5.8.1. Indonesia: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  - 8.5.8.2. Indonesia: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  - 8.5.8.3. Indonesia: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.9. Geriatric Medicines Market - South Korea
  - 8.5.9.1. South Korea: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  - 8.5.9.2. South Korea: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  - 8.5.9.3. South Korea: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.10. Geriatric Medicines Market - Australia
  - 8.5.10.1. Australia: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  - 8.5.10.2. Australia: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  - 8.5.10.3. Australia: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.5.11. Geriatric Medicines Market - Rest of Asia Pacific
  - 8.5.11.1. Rest of Asia Pacific: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  - 8.5.11.2. Rest of Asia Pacific: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  - 8.5.11.3. Rest of Asia Pacific: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
8.6. Geriatric Medicines Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
- 8.6.2. Middle East & Africa: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
- 8.6.3. Middle East & Africa: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.6.4. Geriatric Medicines Market - Saudi Arabia
  - 8.6.4.1. Saudi Arabia: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  - 8.6.4.2. Saudi Arabia: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  - 8.6.4.3. Saudi Arabia: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.6.5. Geriatric Medicines Market - UAE
  - 8.6.5.1. UAE: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  - 8.6.5.2. UAE: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  - 8.6.5.3. UAE: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.6.6. Geriatric Medicines Market - Israel
  - 8.6.6.1. Israel: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  - 8.6.6.2. Israel: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  - 8.6.6.3. Israel: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.6.7. Geriatric Medicines Market - South Africa
  - 8.6.7.1. South Africa: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  - 8.6.7.2. South Africa: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  - 8.6.7.3. South Africa: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.6.8. Geriatric Medicines Market - Rest of Middle East & Africa
  - 8.6.8.1. Rest of Middle East & Africa: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  - 8.6.8.2. Rest of Middle East & Africa: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  - 8.6.8.3. Rest of Middle East & Africa: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
8.7. Geriatric Medicines Market - Latin America
- 8.7.1. Latin America: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
- 8.7.2. Latin America: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
- 8.7.3. Latin America: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.7.4. Geriatric Medicines Market - Mexico
  - 8.7.4.1. Mexico: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  - 8.7.4.2. Mexico: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  - 8.7.4.3. Mexico: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.7.5. Geriatric Medicines Market - Brazil
  - 8.7.5.1. Brazil: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  - 8.7.5.2. Brazil: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  - 8.7.5.3. Brazil: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.7.6. Geriatric Medicines Market - Argentina
  - 8.7.6.1. Argentina: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  - 8.7.6.2. Argentina: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  - 8.7.6.3. Argentina: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)
- 8.7.7. Geriatric Medicines Market - Rest of Latin America
  - 8.7.7.1. Rest of Latin America: Geriatric Medicines Market, by Therapeutics, 2020-2034 (USD Billion)
  - 8.7.7.2. Rest of Latin America: Geriatric Medicines Market, by Condition, 2020-2034 (USD Billion)
  - 8.7.7.3. Rest of Latin America: Geriatric Medicines Market, by Distribution Channel, 2020-2034 (USD Billion)

9. Competitive Landscape

9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

10.1. Pfizer Inc.
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
10.2. Novartis International AG
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
10.3. Sanofi
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
10.4. GlaxoSmithKline
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
10.5. Merck & Co.
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
10.6. AbbVie
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
10.7. AstraZeneca
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
10.8. Johnson & Johnson
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
10.9. Eli Lilly and Company
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
10.10. Roche
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development